Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Size, Value And Growth Trajectory Through 2030
The artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market has experienced substantial expansion in recent years. This market is projected to expand from $1.24 billion in 2025 to $1.47 billion in 2026, achieving a compound annual growth rate (CAGR) of 18.6%. During the historic period, this growth was primarily driven by factors such as an increase in the prevalence of neurological disorders, the early adoption of robotic rehabilitation devices, significant advancements in sensor technologies, a rising demand for intensive rehabilitation therapies, and the proliferation of rehabilitation centers.
The artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market is projected for swift expansion in the coming years, with its size anticipated to reach $2.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 18.3%. This projected growth is primarily driven by factors such as AI-enabled adaptive rehabilitation, the increasing availability of home-based neurorehabilitation solutions, a growing geriatric population, improved reimbursement support for robotic therapy, and the integration of cloud-based analytics. Key emerging trends within this forecast period encompass personalized AI-driven rehabilitation programs, advanced adaptive motion assistance systems, robust data-driven therapy outcome tracking, the rise of home-based robotic rehabilitation, and seamless integration with existing clinical rehabilitation protocols.
Get A Free Sample Report With In-Depth Market Insights:
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Development Factors: What’s Supporting Demand?
The increasing occurrence of neurological disorders is anticipated to drive the expansion of the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market going forward. Neurological disorders are health issues impacting the brain, spinal cord, and nerves, which can lead to deficiencies in movement, cognition, sensation, or other bodily functions. The worldwide increase in neurological disorders is primarily attributed to an aging population, given that older adults are more susceptible to ailments such as stroke, dementia, and Parkinson’s disease, all of which typically become more common as people get older. Artificial intelligence (AI)-enhanced neurorehabilitation exoskeletons assist individuals affected by neurological disorders by offering tailored, flexible therapy that enhances motor function, speeds up recuperation, and makes up for restricted motion through continuous observation and smart customization to suit individual patient requirements. For instance, in March 2023, according to the Alzheimer’s Association, a US-based nonprofit voluntary health organization, approximately 6.7 million Americans aged 65 and older are living with Alzheimer’s dementia, and this number is projected to rise to 13.8 million by 2060. Consequently, the increasing prevalence of neurological disorders is propelling the expansion of the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market.
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Segmentation: How Does The Market Break Down By Category?
The artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Mobility Type: Mobile, Stationary
3) By Application: Stroke Rehabilitation, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis
4) By End-User: Hospitals And Clinics, Rehabilitation Centers, Home Care Settings
Subsegments:
1) By Hardware: Exoskeleton Frames, Actuators And Motors, Sensors And Wearable Devices, Control Units And Embedded Electronics
2) By Software: Motion Planning Software, Rehabilitation Protocol Software, Data Analytics And Monitoring Software, Connectivity And Integration Software
3) By Services: Implementation And Setup Services, Training And Education Services, Maintenance And Support Services, Remote Monitoring And Assistance Services
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Transformation Trends: What Innovations Are Driving Change?
Leading firms within the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton sector are concentrating on incorporating novel solutions like robotic control systems to boost mobility, ensure stability, and customize rehabilitation results. These robotic control systems represent technologies designed to govern and synchronize the actions of a robot or exoskeleton, thereby assisting users in walking, standing, and executing everyday tasks securely and effectively through accurate, steady, and adaptable movement. As an illustration, in May 2025, Wandercraft SAS, a robotics company situated in France, initiated clinical trials in the U.S. for its AI-powered Personal Exoskeleton. This device integrates sophisticated physical AI with robotic control systems to enable individuals suffering from spinal cord injuries, stroke, and other mobility impairments to stand, walk, and traverse different terrains with confidence. By continuously adapting to the user’s movements in real time, it improves mobility, bolsters stability, and optimizes rehabilitation results. Featuring a joystick-controlled system alongside intelligent algorithms that predict alterations in weight, surface type, and speed, the exoskeleton fosters enhanced independence while mitigating secondary health issues associated with extended reliance on wheelchairs.
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Key Participants And Competitive Landscape
Major companies operating in the artificial intelligence (ai)-enhanced neurorehabilitation exoskeleton market are Ottobock SE & Co. KGaA, Shanghai Fourier Intelligence Co. Ltd., Kinova Inc., Cyberdyne Inc., Hocoma AG, Myomo Inc., Neofect Co. Ltd., Ekso Bionics Holdings Inc., ReWalk Robotics Ltd., AlterG Inc., RENU ROBOTICS CORPORATION, ExoAtlet Global S.A., REEV Robotics, Bionik Laboratories Corp., Rex Bionics PLC, Wearable Robotics Srl, Gogoa Mobility Robots S.L., Technaid S.L., Bionic Yantra Pvt. Ltd., MediTouch Inc.
View The Full Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Report:
Artificial Intelligence (AI)-Enhanced Neurorehabilitation Exoskeleton Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market in 2025. The regions covered in the artificial intelligence (AI)-enhanced neurorehabilitation exoskeleton market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Leave a Reply